Related references
Note: Only part of the references are listed.Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?
Ruben A. T. Mars et al.
GASTROENTEROLOGY (2021)
The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes
Amanda Jacobson et al.
MUCOSAL IMMUNOLOGY (2021)
Human Milk Oligosaccharides Modulate Fecal Microbiota and Are Safe for Use in Children With Overweight: A Randomized Controlled Trial
Cilius Esmann Fonvig et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2021)
Exploration of the microbiota and metabolites within body fluids could pinpoint novel disease mechanisms
Jordi Mayneris-Perxachs et al.
FEBS JOURNAL (2020)
Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
Johanna Sundin et al.
SCIENTIFIC REPORTS (2020)
Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics
Bernard Berger et al.
mBio (2020)
2′-Fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice
Sunhye Lee et al.
NUTRIENTS (2020)
The Protective Effects of 2'-Fucosyllactose AgainstE. ColiO157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
Yuanyifei Wang et al.
NUTRIENTS (2020)
The Application of Metabolomics to Probiotic and Prebiotic Interventions in Human Clinical Studies
Thomas M. O'Connell
METABOLITES (2020)
Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
Tong Liu et al.
BMC MICROBIOLOGY (2020)
Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome
Ruben A. T. Mars et al.
CELL (2020)
Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double-blind, placebo-controlled study
Cristina Iribarren et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2020)
Functional Gastrointestinal Disorders 2 Irritable bowel syndrome
Alexander C. Ford et al.
LANCET (2020)
Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function
Tanja Suligoj et al.
NUTRIENTS (2020)
Blends of Human Milk Oligosaccharides Confer Intestinal Epithelial Barrier Protection In Vitro
Jane M. Natividad et al.
NUTRIENTS (2020)
Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial
Olafur S. Palsson et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Human gut microbiota/microbiome in health and diseases: a review
Eman Zakaria Gomaa
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2020)
The potential of human milk oligosaccharides to impact the microbiota-gut-brain axis through modulation of the gut microbiota
Alia H. Al-Khafaji et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease
Annalisa Bosi et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2020)
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review
Rapat Pittayanon et al.
GASTROENTEROLOGY (2019)
Immunomodulatory and Prebiotic Effects of 2′-Fucosyllactose in Suckling Rats
Ignasi Azagra-Boronat et al.
FRONTIERS IN IMMUNOLOGY (2019)
Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health
Kaitlyn Oliphant et al.
MICROBIOME (2019)
2′-Fucosyllactose alters the composition and activity of gut microbiota from formula-fed infants receiving complementary feeding in a validated intestinal model
P. Van den Abbeele et al.
JOURNAL OF FUNCTIONAL FOODS (2019)
Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome
Shengtao Zhu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Metabolomics analysis revealed metabolic changes in patients with diarrhea-predominant irritable bowel syndrome and metabolic responses to a synbiotic yogurt intervention
Hamid Noorbakhsh et al.
EUROPEAN JOURNAL OF NUTRITION (2019)
On the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities
Brandie D. Wagner et al.
FRONTIERS IN MICROBIOLOGY (2018)
Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation
Sean M. P. Bennet et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Human Milk Oligosaccharides: 2-Fucosyllactose (2-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
Yvan Vandenplas et al.
NUTRIENTS (2018)
Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum
Aina Gotoh et al.
SCIENTIFIC REPORTS (2018)
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome
Julien Tap et al.
GASTROENTEROLOGY (2017)
Asparagine preserves intestinal barrier function from LPS-induced injury and regulates CRF/CRFR signaling pathway
Huiling Zhu et al.
INNATE IMMUNITY (2017)
Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity
Sharon M. Donovan et al.
ANNALS OF NUTRITION AND METABOLISM (2016)
Nutrition meets the microbiome: micronutrients and the microbiota
Hans K. Biesalski
NUTRITION AND THE MICROBIOME (2016)
Oral supplementation of healthy adults with 2-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
Emma Elison et al.
BRITISH JOURNAL OF NUTRITION (2016)
Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2′-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial
Karen C. Goehring et al.
JOURNAL OF NUTRITION (2016)
Irritable bowel syndrome
Paul Enck et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Effect of diet on the intestinal microbiota and its activity
Erwin G. Zoetendal et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Direct Evidence for the Presence of Human Milk Oligosaccharides in the Circulation of Breastfed Infants
Karen C. Goehring et al.
PLOS ONE (2014)
Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
Paul J. Kennedy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies
Anna Klindworth et al.
NUCLEIC ACIDS RESEARCH (2013)
Human milk oligosaccharide consumption by intestinal microbiota
A. Marcobal et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Human milk oligosaccharides: Every baby needs a sugar mama
Lars Bode
GLYCOBIOLOGY (2012)
Variation of human milk oligosaccharides in relation to milk groups and lactational periods
Stephan Thurl et al.
BRITISH JOURNAL OF NUTRITION (2010)
Bacterial competition: surviving and thriving in the microbial jungle
Michael E. Hibbing et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Patrick D. Schloss et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)
Activation of the mucosal immune system in irritable bowel syndrome
VS Chadwick et al.
GASTROENTEROLOGY (2002)
The validity of the Hospital Anxiety and Depression Scale - An updated literature review
I Bjelland et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
Human milk oligosaccharides are minimally digested in vitro
MJ Gnoth et al.
JOURNAL OF NUTRITION (2000)
Variability of human milk neutral oligosaccharides in a diverse population
RM Erney et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2000)